How much profit has Resonance Health made this year?
Resonance Health has made -780,360 AUD this year.
Resonance Health Net Income 2024
Resonance Health Net Income
-780,360 AUD
Ticker
RHT.AX
ISIN
AU000000RHT2
WKN
A0BK8V
In 2024, Resonance Health's profit amounted to -780,360 AUD, a -31.65% increase from the -1.14 M AUD profit recorded in the previous year.
The Resonance Health Net Income history
| YEAR | NET INCOME (undefined AUD) |
|---|---|
| 2023 | -0.78 |
| 2022 | -1.14 |
| 2021 | 0.59 |
| 2020 | -0.72 |
| 2019 | 1.27 |
| 2018 | 0.22 |
| 2017 | -0.3 |
| 2016 | -0.38 |
| 2015 | 0.46 |
| 2014 | -0.07 |
| 2013 | -0.2 |
| 2012 | -0.27 |
| 2011 | -0.32 |
| 2010 | -0.1 |
| 2009 | 0.62 |
| 2008 | -0.04 |
| 2007 | -0.73 |
| 2006 | -16.06 |
| 2005 | -1.9 |
| 2004 | -1.26 |
Resonance Health Revenue, EBIT, Net Income AU000000RHT2 · A0BK8V
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Resonance Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Resonance Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Resonance Health’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Resonance Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Resonance Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Resonance Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Resonance Health’s growth potential.
Resonance Health Revenue, EBIT and net profit per share
| Date | Resonance Health Revenue | Resonance Health EBIT | Resonance Health Net Income |
|---|---|---|---|
| 2023 | 4.51 M undefined | -1.52 M undefined | -780,360 undefined |
| 2022 | 3.83 M undefined | -1.77 M undefined | -1.14 M undefined |
| 2021 | 3.82 M undefined | 225,670 undefined | 585,860 undefined |
| 2020 | 3.71 M undefined | -1.14 M undefined | -715,080 undefined |
| 2019 | 3.66 M undefined | 904,310 undefined | 1.27 M undefined |
| 2018 | 2.91 M undefined | -246,270 undefined | 224,620 undefined |
| 2017 | 2.53 M undefined | -574,140 undefined | -304,220 undefined |
| 2016 | 2.6 M undefined | -444,760 undefined | -384,370 undefined |
| 2015 | 2.68 M undefined | 120,460 undefined | 463,230 undefined |
| 2014 | 2.31 M undefined | 100,000 undefined | -70,000 undefined |
| 2013 | 1.71 M undefined | -520,000 undefined | -200,000 undefined |
| 2012 | 1.79 M undefined | -490,000 undefined | -270,000 undefined |
| 2011 | 1.93 M undefined | -360,000 undefined | -320,000 undefined |
| 2010 | 2.01 M undefined | -220,000 undefined | -100,000 undefined |
| 2009 | 2.39 M undefined | 570,000 undefined | 620,000 undefined |
| 2008 | 1.88 M undefined | -220,000 undefined | -40,000 undefined |
| 2007 | 2.16 M undefined | -670,000 undefined | -730,000 undefined |
| 2006 | 620,000 undefined | -3.5 M undefined | -16.06 M undefined |
| 2005 | 280,000 undefined | -3.01 M undefined | -1.9 M undefined |
| 2004 | 50,000 undefined | -2.02 M undefined | -1.26 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 50,000 AUD | -2.02 M AUD | -1.26 M AUD |
| 2005 | 280,000 AUD | -3.01 M AUD | -1.9 M AUD |
| 2006 | 620,000 AUD | -3.5 M AUD | -16.06 M AUD |
| 2007 | 2.16 M AUD | -670,000 AUD | -730,000 AUD |
| 2008 | 1.88 M AUD | -220,000 AUD | -40,000 AUD |
| 2009 | 2.39 M AUD | 570,000 AUD | 620,000 AUD |
| 2010 | 2.01 M AUD | -220,000 AUD | -100,000 AUD |
| 2011 | 1.93 M AUD | -360,000 AUD | -320,000 AUD |
| 2012 | 1.79 M AUD | -490,000 AUD | -270,000 AUD |
| 2013 | 1.71 M AUD | -520,000 AUD | -200,000 AUD |
| 2014 | 2.31 M AUD | 100,000 AUD | -70,000 AUD |
| 2015 | 2.68 M AUD | 120,460 AUD | 463,230 AUD |
| 2016 | 2.6 M AUD | -444,760 AUD | -384,370 AUD |
| 2017 | 2.53 M AUD | -574,140 AUD | -304,220 AUD |
| 2018 | 2.91 M AUD | -246,270 AUD | 224,620 AUD |
| 2019 | 3.66 M AUD | 904,310 AUD | 1.27 M AUD |
| 2020 | 3.71 M AUD | -1.14 M AUD | -715,080 AUD |
| 2021 | 3.82 M AUD | 225,670 AUD | 585,860 AUD |
| 2022 | 3.83 M AUD | -1.77 M AUD | -1.14 M AUD |
| 2023 | 4.51 M AUD | -1.52 M AUD | -780,360 AUD |
Resonance Health stock margins AU000000RHT2 · A0BK8V
The Resonance Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Resonance Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Resonance Health.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Resonance Health's sales revenue. A higher gross margin percentage indicates that the Resonance Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Resonance Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Resonance Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Resonance Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Resonance Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Resonance Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Resonance Health Margin History
| Resonance Health Gross margin | Resonance Health Profit margin | Resonance Health EBIT margin | Resonance Health Profit margin |
|---|---|---|---|
| 2023 | 0 % | -33.65 % | -17.3 % |
| 2022 | 0 % | -46.18 % | -29.8 % |
| 2021 | 0 % | 5.91 % | 15.35 % |
| 2020 | 0 % | -30.69 % | -19.28 % |
| 2019 | 0 % | 24.7 % | 34.69 % |
| 2018 | 0 % | -8.46 % | 7.71 % |
| 2017 | 0 % | -22.66 % | -12.01 % |
| 2016 | 0 % | -17.13 % | -14.8 % |
| 2015 | 0 % | 4.5 % | 17.31 % |
| 2014 | 0 % | 4.33 % | -3.03 % |
| 2013 | 0 % | -30.41 % | -11.7 % |
| 2012 | 0 % | -27.37 % | -15.08 % |
| 2011 | 0 % | -18.65 % | -16.58 % |
| 2010 | 0 % | -10.95 % | -4.98 % |
| 2009 | 0 % | 23.85 % | 25.94 % |
| 2008 | 0 % | -11.7 % | -2.13 % |
| 2007 | 0 % | -31.02 % | -33.8 % |
| 2006 | 0 % | -564.52 % | -2,590.32 % |
| 2005 | 0 % | -1,075 % | -678.57 % |
| 2004 | 0 % | -4,040 % | -2,520 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 0 % | -4,040 % | -2,520 % |
| 2005 | 0 % | -1,075 % | -678.57 % |
| 2006 | 0 % | -564.52 % | -2,590.32 % |
| 2007 | 0 % | -31.02 % | -33.8 % |
| 2008 | 0 % | -11.7 % | -2.13 % |
| 2009 | 0 % | 23.85 % | 25.94 % |
| 2010 | 0 % | -10.95 % | -4.98 % |
| 2011 | 0 % | -18.65 % | -16.58 % |
| 2012 | 0 % | -27.37 % | -15.08 % |
| 2013 | 0 % | -30.41 % | -11.7 % |
| 2014 | 0 % | 4.33 % | -3.03 % |
| 2015 | 0 % | 4.5 % | 17.31 % |
| 2016 | 0 % | -17.13 % | -14.8 % |
| 2017 | 0 % | -22.66 % | -12.01 % |
| 2018 | 0 % | -8.46 % | 7.71 % |
| 2019 | 0 % | 24.7 % | 34.69 % |
| 2020 | 0 % | -30.69 % | -19.28 % |
| 2021 | 0 % | 5.91 % | 15.35 % |
| 2022 | 0 % | -46.18 % | -29.8 % |
| 2023 | 0 % | -33.65 % | -17.3 % |
Resonance Health Aktienanalyse
What does Resonance Health do?
Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Resonance Health's Profit Margins
The profit margins of Resonance Health represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Resonance Health's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Resonance Health's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Resonance Health's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Resonance Health’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Resonance Health stock
How has the profit developed compared to last year?
The profit has increased by -31.65% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Resonance Health publish its earnings?
Resonance Health publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Resonance Health?
The profits of Resonance Health are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Resonance Health?
You can learn more about the earnings of Resonance Health by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Resonance Health pay?
Over the past 12 months, Resonance Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Resonance Health is expected to pay a dividend of 0 AUD.
What is the dividend yield of Resonance Health?
The current dividend yield of Resonance Health is .
When does Resonance Health pay dividends?
Resonance Health pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Resonance Health?
Resonance Health paid dividends every year for the past 0 years.
What is the dividend of Resonance Health?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Resonance Health located?
Resonance Health is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resonance Health kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resonance Health from 9/10/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.
When did Resonance Health pay the last dividend?
The last dividend was paid out on 9/10/2024.
What was the dividend of Resonance Health in the year 2023?
In the year 2023, Resonance Health distributed 0 AUD as dividends.
In which currency does Resonance Health pay out the dividend?
The dividends of Resonance Health are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Resonance Health
Our stock analysis for Resonance Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resonance Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Resonance Health Revenue
- Resonance Health Net Income
- Resonance Health P/E
- Resonance Health P/S
- Resonance Health EBIT
- Resonance Health Dividend
- Resonance Health Stocks
- Resonance Health Market capitalization
- Resonance Health Debt
- Resonance Health Liabilities
- Resonance Health Equity
- Resonance Health AAQS
- Resonance Health Employees
- Resonance Health ROE
- Resonance Health ROA
- Resonance Health ROCE
